|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$345,571
|
N/A
|
National Institutes of Health
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
$3,961
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
COG NCTN Network Group Operations Center
|
1U10CA180886-01
|
$26,616,497
|
$1,064,660
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,704,173
|
$735,209
|
Custer, Mary
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA008748-48
|
$12,352,942
|
$123,529
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Cancer Center Support Grant
|
5P30CA006516-49
|
$10,827,666
|
$108,277
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S5
|
$10,116,159
|
$101,162
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Regional Oncology Research Center
|
5P30CA006973-51
|
$6,785,409
|
$67,854
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Children's Oncology Group Statistics and Data Center
|
1U10CA180899-01
|
$6,735,202
|
$673,520
|
DEVIDAS, MEENAKSHI
|
UNIVERSITY OF FLORIDA
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-08S1
|
$6,300,000
|
$315,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
2P30CA021765-35
|
$5,765,603
|
$461,248
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,326,567
|
$426,125
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-20
|
$4,686,132
|
$46,861
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,436,451
|
$221,823
|
Gulley, James
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA016042-39
|
$4,295,192
|
$42,952
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Adult Leukemia Research Center
|
5P01CA018029-39
|
$4,098,686
|
$368,882
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-20
|
$4,071,218
|
$407,122
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant
|
2P30CA013696-40
|
$3,596,904
|
$35,969
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S7
|
$3,000,000
|
$120,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Consolidated Basic Cancer Research Program
|
2P30CA010815-45
|
$2,516,380
|
$50,328
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-09
|
$2,162,001
|
$562,120
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
SPORE in Lymphoma
|
5P50CA126752-08
|
$2,162,000
|
$756,700
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer Center Support Grant
|
5P30CA033572-31
|
$2,119,061
|
$63,572
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
5U01CA121947-08
|
$1,900,000
|
$95,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
|
ZIA BC 008753
|
$1,751,990
|
$262,798
|
Pastan, Ira
|
CCR (NCI)
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S5
|
$1,543,656
|
$61,746
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB)
|
3U24CA114766-08S1
|
$1,510,732
|
$151,073
|
RAMIREZ, NILSA
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
Biochemical Basis of T Cell Activation
|
ZIA BC 010304
|
$1,388,187
|
$694,093
|
Samelson, Lawrence
|
CCR (NCI)
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S4
|
$1,163,256
|
$46,530
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
IL-2/IL-15 cytokine receptor: implications for cancer therapy and vaccine
|
ZIA SC 004002
|
$1,151,994
|
$230,399
|
Waldmann, Thomas
|
CCR (NCI)
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,130,654
|
$113,065
|
Gress, Ronald
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,097,105
|
$54,855
|
Restifo, Nicholas
|
CCR (NCI)
|
|
DNA Repair
|
ZIA BC 010283
|
$951,397
|
$161,738
|
Nussenzweig, Andre
|
CCR (NCI)
|
|
Lymphoma Disease Discovery and Definition
|
ZIA SC 000550
|
$854,050
|
$85,405
|
Jaffe, Elaine
|
CCR (NCI)
|
|
NCI National Clinical Trials Network-Network Lead Academic Participating Sites
|
1U10CA180836-01
|
$785,950
|
$19,649
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
Immunohistochemistry Core Laboratory
|
ZIC BC 011087
|
$768,459
|
$23,054
|
Raffeld, Mark
|
CCR (NCI)
|
|
Novel Pathogen Associated Cancers (PQ12)
|
5R01CA170386-03
|
$722,856
|
$144,571
|
GALLOWAY, DENISE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
IL-15 in the immunotherapy of cancer
|
ZID BC 011539
|
$715,934
|
$178,983
|
Conlon, Kevin
|
CCR (NCI)
|
|
Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation
|
5R01CA174794-02
|
$688,198
|
$688,198
|
KRULL, KEVIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Epstein-Barr Virus LMP1-Mediated Oncogenecity
|
5R01CA085180-13
|
$680,363
|
$340,182
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$679,729
|
$135,946
|
Hakim, Frances
|
CCR (NCI)
|
|
Human Immune Responses to Tumor Antigens for Cancer Vaccine Development
|
ZIA BC 010598
|
$594,675
|
$29,734
|
Schlom, Jeffrey
|
CCR (NCI)
|
|
Communication Skills Intervention to Promote Transition into Survivorship
|
5R01CA151899-04
|
$574,569
|
$287,285
|
HORWITZ, STEVEN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$551,199
|
$110,240
|
Figg, William
|
CCR (NCI)
|
|
Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation
|
5R01CA047006-27
|
$548,274
|
$274,137
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133 - 04180
|
$538,069
|
$10,761
|
Linet, Martha
|
DCEG (NCI)
|
|
BETR Therapy for Herpesvirus-Associated Tumors
|
5R01CA138636-05
|
$520,698
|
$260,349
|
POMPER, MARTIN
|
JOHNS HOPKINS UNIVERSITY
|
|
Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction
|
5R01CA140245-05
|
$519,121
|
$519,121
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Lymphoma Studies
|
ZIA SC 006741
|
$491,316
|
$98,263
|
Wilson, Wyndham
|
CCR (NCI)
|
|
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
|
ZIA BC 011214
|
$468,501
|
$93,700
|
Park, Jung-Hyun
|
CCR (NCI)
|
Total relevant funding to Hodgkins disease for this search: $15,437,951
|